BI 44370

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BI 44370, covering 2013-11-01 to 2013-11-01. Get the full timeline:

Most recent: Clinical Trial Update: Relative Bioavailability of a Single Dose of BI 44370 Tablet During and Between Migraine Attacks [Phase 1]